Vaccination against hepatitis B: the Italian strategy

Vaccine

Volumn 11, Issue 5, 1993, Pages 521-524

  Zanetti, A R ^a   Tanzi, E ^a   Romano, L ^a   Grappasonni, I ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Italy; vaccination schedule; Viral hepatitis B

Indexed keywords

HEPATITIS B VACCINE;

CONFERENCE PAPER; HEPATITIS B; HUMAN; IMMUNOGENICITY; ITALY; NORMAL HUMAN; SAFETY; VACCINATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMAN; IMMUNIZATION SCHEDULE; INFANT; ITALY; MALE; VACCINATION;

EID: 0027264058     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(93)90222-J     Document Type: Article

References (46)

1. Immunization against hepatitis B: Report on a WHO Meeting on Viral Hepatitis in Europe
2. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees
3. Antibodies to a synthetic peptide from the pre-S 120–145 region of the hepatitis B virus envelope are virus-neutralizing
4. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen
5. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass non-responsiveness of the pre-S(2) and S regions of HBsAg
6. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States
7. A controlled clinical trial of the efficacy of hepatitis B vaccine (Heptavax): a final report
8. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection
9. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multicentre efficacy trial among homosexual men
10. Immune response to hepatitis B vaccine in staff and patients in renal dialysis units
11. Efficacy of a heat-inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo-controlled double blind trial
12. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units
13. Prevention of hepatitis B by active and passive-active immunization
14. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal)
15. Long term immunogenicity and efficacy of hepatitis B vaccine in homosexual men
16. Clinical evaluation of a recombinant hepatitis B vaccine
17. Safety and immunogenicity of a recombinant hepatitis B vaccine
18. Yeast recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
19. Immunogenicity and safety of a yeast-derived recombinant DNA hepatitis vaccine in health care workers
20. Clinical experience with a yeast-derived hepatitis B vaccine
21. Immunization of young adults with two yeast-derived hepatitis B vaccines
22. Yeast-derived hepatitis B vaccine in dental students.
23. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units
24. Hepatitis B vaccination in the elderly
25. Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLVIII positive patients
26. Impaired responsiveness of homosexual men with HIV antibodies to plasma-derived hepatitis B vaccine
27. Active immunization against hepatitis B: immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males
28. Reduced immunogenicity of recombinant yeast-derived hepatitis B vaccine in HIV-antibody positive male homosexuals
29. Site of injection and response to hepatitis vaccine
30. Failure of intradermal hepatitis B vaccine in Gambian children
31. Long-term persistence of protective antibody after hepatitis B vaccination of healthy adults
32. Duration of immunity after hepatitis B vaccination: efficacy of low dose booster vaccine
33. Long-term efficacy of hepatitis B vaccination in healthy adults
34. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in anti-HIV positive and anti-HIV negative haemophiliacs
35. Hepatitis B vaccination: how long does protection last?
36. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects
37. Control of hepatitis B by immunization: global perspectives
38. Host responses to hepatitis B infection in patients with primary hepatic carcinoma and their families: a case/control study in Senegal, West Africa
39. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer
40. Epidemiology of hepatocellular carcinoma
41. Update on hepatitis B prevention
42. Toward universal vaccination against hepatitis B virus
43. SEIEVA e campagna vaccinale anti-epatite B in Italia
44. Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy
45. Mass vaccination against hepatitis B in infants in Italy
46. Gazzetta Ufficiale della Repubblica Italiana